AAAAAA

   
Results: 1-17 |
Results: 17

Authors: AUDINOT V NEWMANTANCREDI A GOBERT A RIVET JM BROCCO M LEJEUNE F GLUCK L DESPOSTE I BERVOETS K DEKEYNE A MILLAN MJ
Citation: V. Audinot et al., A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194()), The Journal of pharmacology and experimental therapeutics, 287(1), 1998, pp. 187-197

Authors: MILLAN MJ SCHREIBER R DEKEYNE A RIVET JM BERVOETS K MAVRIDIS M SEBBAN C MAURELREMY S NEWMANTANCREDI A SPEDDING M MULLER O LAVIELLE G BROCCO M
Citation: Mj. Millan et al., S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1356-1373

Authors: MILLAN MJ BROCCO M VEIGA S CISTARELLI L MELON C GOBERT A
Citation: Mj. Millan et al., WAY-100,635 ENHANCES BOTH THE ANTIDEPRESSANT ACTIONS OF DULOXETINE AND ITS INFLUENCE ON DIALYSATE LEVELS OF SEROTONIN IN FRONTAL-CORTEX, European journal of pharmacology, 341(2-3), 1998, pp. 165-167

Authors: MILLAN MJ NEWMANTANCREDI A RIVET JM BROCCO M LACROIX P AUDINOT V CISTARELLI L GOBERT A
Citation: Mj. Millan et al., S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .1. INTERACTION WITH CLONED HUMAN (H)5-HT1A, DOPAMINE HD(2) HD(3) AND H-ALPHA(2A)-ADRENERGIC RECEPTORS IN RELATION TO MODULATION OF CORTICAL MONOAMINE RELEASE AND ACTIVITY IN MODELS OF POTENTIAL ANTIDEPRESSANT ACTIVITY/, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 132-147

Authors: MILLAN MJ HJORTH S SAMANIN R SCHREIBER R JAFFARD R DELADONCHAMPS B VEIGA S GOUMENT B PEGLION JL SPEDDING M BROCCO M
Citation: Mj. Millan et al., S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .2. MODULATION OF HIPPOCAMPAL SEROTONIN RELEASE IN RELATION TO POTENTIAL ANXIOLYTIC PROPERTIES, The Journal of pharmacology and experimental therapeutics, 282(1), 1997, pp. 148-161

Authors: MILLAN MJ GRESSIER H BROCCO M
Citation: Mj. Millan et al., THE DOPAMINE-D-3-RECEPTOR ANTAGONIST, (-S-14297, BLOCKS THE CATALEPTIC PROPERTIES OF HALOPERIDOL IN RATS()), European journal of pharmacology, 321(3), 1997, pp. 7-9

Authors: CARRIZO ME ROMERO JM MIOZZO MC BROCCO M PANZETTA P CURTINO JA
Citation: Me. Carrizo et al., BIOSYNTHESIS OF PROTEOGLYCOGEN - MODULATION OF GLYCOGENIN EXPRESSION IN THE DEVELOPING CHICKEN, Biochemical and biophysical research communications, 240(1), 1997, pp. 142-145

Authors: SCHREIBER R BROCCO M DELADONCHAMPS BL MILLAN MJ
Citation: R. Schreiber et al., INVOLVEMENT OF 5-HT1A RECEPTORS IN THE ANXIOLYTIC ACTION OF S-14671 IN THE PIGEON CONFLICT TEST, Pharmacology, biochemistry and behavior, 51(2-3), 1995, pp. 211-215

Authors: SCHREIBER R BROCCO M DELADONCHAMPS BL MONNEYRON S MILLAN MJ
Citation: R. Schreiber et al., A DRUG DISCRIMINATION ANALYSIS OF THE ACTIONS OF NOVEL SEROTONIN(1A) RECEPTOR LIGANDS IN THE RAT USING THE 5-HT1A RECEPTOR AGONIST, 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 822-831

Authors: MILLAN MJ PEGLION JL VIAN J RIVET JM BROCCO M GOBERT A NEWMANTANCREDI A DACQUET C BERVOETS K GIRARDON S JACQUES V CHAPUT C AUDINOT V
Citation: Mj. Millan et al., FUNCTIONAL CORRELATES OF DOPAMINE D-3 RECEPTOR ACTIVATION IN THE RAT IN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .1. ACTIVATION OF POSTSYNAPTIC D-3, RECEPTORS MEDIATES HYPOTHERMIA, WHEREAS BLOCKADE OF D-2 RECEPTORS ELICITS PROLACTIN SECRETION AND CATALEPSY()), The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 885-898

Authors: MILLAN MJ RIVET JM AUDINOT V GOBERT A LEJEUNE F BROCCO M NEWMANTANCREDI A MAURELREMY S BERVOETS K
Citation: Mj. Millan et al., ANTAGONIST PROPERTIES OF LY-165,163 AT PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE D-2, D-3, AND D-1 RECEPTORS - MODULATION OF AGONIST ACTIONS AT5-HT1A RECEPTORS IN-VIVO, The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1418-1427

Authors: SCHREIBER R BROCCO M AUDINOT V GOBERT A VEIGA S MILLAN MJ
Citation: R. Schreiber et al., (1-(2,5-DIMETHOXY-4 IODOPHENYL)-2-AMINOPROPANE)-INDUCED HEAD-TWITCHESIN THE RAT ARE MEDIATED BY 5-HYDROXYTRYPTAMINE (5-HT)(2A) RECEPTORS -MODULATION BY NOVEL 5-HT2A 2C ANTAGONISTS, D-1 ANTAGONISTS AND 5-HT1AAGONISTS/, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 101-112

Authors: PEGLION JL CANTON H BERVOETS K AUDINOT V BROCCO M GOBERT A LEMAROUILLEGIRARDON S MILLAN MJ
Citation: Jl. Peglion et al., CHARACTERIZATION OF POTENT AND SELECTIVE ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS IN A SERIES OF N4-SUBSTITUTED ARYLPIPERAZINES, Journal of medicinal chemistry, 38(20), 1995, pp. 4044-4055

Authors: MILLAN MJ AUDINOT V BROCCO M MAURELREMY S JOLY F NEWMANTANCREDI A CANTON H HAUTEFAYE P SPEDDING M MULLER O LAVIELLE G
Citation: Mj. Millan et al., S-16924 - A PYRROLIDINE-SUBSTITUTED BENZODIOXANE WITH HIGHER AFFINITYAT 5-HT1A 2A/2C THAN D2 RECEPTORS, AND AN ATYPICAL ANTIPSYCHOTIC PROFILE IN THE RAT/, British Journal of Pharmacology, 114, 1995, pp. 156-156

Authors: MILLAN MJ CANTON H GOBERT A LEJEUNE F RIVET JM BERVOETS K BROCCO M WIDDOWSON P MENNINI T AUDINOT V HONORE P RENOUARD A LEMAROUILLEGIRARDON S VERRIELE L GRESSIER H PEGLION JL
Citation: Mj. Millan et al., NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS, The Journal of pharmacology and experimental therapeutics, 268(1), 1994, pp. 337-352

Authors: SCHREIBER R BROCCO M GOBERT A VEIGA S MILLAN MJ
Citation: R. Schreiber et al., THE POTENT ACTIVITY OF THE 5-HT1A RECEPTOR AGONISTS, S-14506 AND S-14671, IN THE RAT FORCED SWIM TEST IS BLOCKED BY NOVEL 5-HT1A-RECEPTOR ANTAGONISTS, European journal of pharmacology, 271(2-3), 1994, pp. 537-541

Authors: SCHREIBER R BROCCO M MILLAN MJ
Citation: R. Schreiber et al., BLOCKADE OF THE DISCRIMINATIVE STIMULUS EFFECTS OF DOI BY MDL-100,907AND THE ATYPICAL ANTIPSYCHOTICS, CLOZAPINE AND RISPERIDONE, European journal of pharmacology, 264(1), 1994, pp. 99-102
Risultati: 1-17 |